Reviewing Chemours (NYSE:CC) & Its Peers

Chemours (NYSE: CC) is one of 33 public companies in the “Commodity Chemicals” industry, but how does it contrast to its peers? We will compare Chemours to related companies based on the strength of its institutional ownership, valuation, risk, dividends, earnings, profitability and analyst recommendations.

Analyst Recommendations

This is a summary of recent ratings and target prices for Chemours and its peers, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Chemours 0 0 7 0 3.00
Chemours Competitors 107 836 1229 36 2.54

Chemours presently has a consensus target price of $53.57, indicating a potential upside of 8.36%. As a group, “Commodity Chemicals” companies have a potential upside of 1.46%. Given Chemours’ stronger consensus rating and higher probable upside, equities analysts clearly believe Chemours is more favorable than its peers.


This table compares Chemours and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Chemours 4.86% 116.80% 8.10%
Chemours Competitors -29.50% 24.34% 5.63%


Chemours pays an annual dividend of $0.12 per share and has a dividend yield of 0.2%. Chemours pays out 8.3% of its earnings in the form of a dividend. As a group, “Commodity Chemicals” companies pay a dividend yield of 1.8% and pay out 51.5% of their earnings in the form of a dividend.

Institutional and Insider Ownership

74.4% of Chemours shares are owned by institutional investors. Comparatively, 70.9% of shares of all “Commodity Chemicals” companies are owned by institutional investors. 1.1% of Chemours shares are owned by insiders. Comparatively, 7.8% of shares of all “Commodity Chemicals” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Earnings and Valuation

This table compares Chemours and its peers top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Chemours $5.40 billion $7.00 million 34.10
Chemours Competitors $4.01 billion $340.26 million 132.16

Chemours has higher revenue, but lower earnings than its peers. Chemours is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.


Chemours beats its peers on 9 of the 14 factors compared.

Chemours Company Profile

The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2). The Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins. The Chemical Solutions segment is a North American provider of industrial chemicals used in gold production, oil and gas, water treatment and other industries. It delivers customized solutions with a range of industrial and specialty chemical products for markets, including plastics and coatings, refrigeration and air conditioning, industrial, mining and oil refining. Its products include titanium dioxide, refrigerants, industrial fluoropolymer resins and a portfolio of mining and industrial chemicals, including sodium cyanide. As of December 31, 2016, the Company operates 26 production facilities located in 10 countries.

Receive News & Ratings for Chemours Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours Company (The) and related companies with's FREE daily email newsletter.

Leave a Reply